Impact of MenAfriVac in nine countries of the African meningitis belt, 2010–15: an analysis of surveillance data Caroline L Trotter, PhD, Clément Lingani, MSc, Katya Fernandez, MPH, Laura V Cooper, MPhil, André Bita, MD, Carol Tevi-Benissan, PhD, Olivier Ronveaux, MD, Marie-Pierre Préziosi, PhD, James M Stuart, FFPH The Lancet Infectious Diseases Volume 17, Issue 8, Pages 867-872 (August 2017) DOI: 10.1016/S1473-3099(17)30301-8 Copyright © 2017 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved Terms and Conditions
Figure Total annual suspected and confirmed cases of bacterial meningitis across all nine countries in relation to MenAfriVac introduction (dotted line) Nm=N meningitidis. Non-A Nm=other meningococcal serogroups. Non-Nm=Pathogens other than N meningitides. The Lancet Infectious Diseases 2017 17, 867-872DOI: (10.1016/S1473-3099(17)30301-8) Copyright © 2017 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved Terms and Conditions